Back
Travere Therapeutics, Inc. Stock Predictions
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
49
TVTX
Travere Therapeutics, Inc.
Last Price:
$29.8800
Seasonality Move:
5.45%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis NowTravere Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1325.8% based on the past 19 years of stock performance.
-
Travere Therapeutics, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
-
Is Travere Therapeutics, Inc. Stock Undervalued?The current Travere Therapeutics, Inc. [TVTX] share price is $29.9400. The Score for TVTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
TVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Travere Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Travere Therapeutics, Inc. has on average historically risen by 1325.8% based on the past 19 years of stock performance.
Travere Therapeutics, Inc. Stock Rating
Sell
49
Travere Therapeutics, Inc. (TVTX)
is a Sell
Is Travere Therapeutics, Inc. overpriced?
-
Travere Therapeutics, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
Travere Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
travere.com
52-Week Data
52-Week High:
42.1300
52-Week Low:
12.9100
Prediction Charts
Market Cap:
2.7B
Price in USD:
29.9400
Volume:
1.1M
Beta:
52.6374
Technical Analysis
SMA50:
34.5130
SMA100:
30.6605
SMA200:
23.6463
52-Wk Change:
47.42%
Stock Predictions
-
Is Travere Therapeutics, Inc. stock public?Yes, Travere Therapeutics, Inc. is a publicly traded company.
-
What is the Travere Therapeutics, Inc. stock quote today?The Travere Therapeutics, Inc. stock price is 29.9400 USD today.
-
How to buy Travere Therapeutics, Inc. stock online?You can buy Travere Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-6 | 37.7500 | 35.8000 | 38.2350 | 34.5000 |
| Jan-7 | 35.8000 | 36.2800 | 37.4500 | 35.5200 |
| Jan-8 | 35.9000 | 35.6000 | 36.5850 | 35.3300 |
| Jan-9 | 35.4400 | 34.5800 | 36.0700 | 33.9200 |
| Jan-12 | 34.2650 | 34.1000 | 34.5620 | 32.2500 |
| Jan-13 | 23.0095 | 29.1100 | 30.0000 | 22.5900 |
| Jan-14 | 29.0500 | 28.9300 | 29.1791 | 27.3600 |
| Jan-15 | 28.6700 | 28.4000 | 28.9600 | 27.7000 |
| Jan-16 | 28.5000 | 27.8700 | 29.3099 | 27.7750 |
| Jan-20 | 27.0700 | 27.9400 | 28.1710 | 26.8900 |
| Jan-21 | 27.5500 | 28.2500 | 28.2900 | 26.7801 |
| Jan-22 | 28.2000 | 29.7300 | 29.7700 | 28.0000 |
| Jan-23 | 29.6600 | 29.4400 | 30.1624 | 29.0700 |
| Jan-26 | 29.2000 | 29.9400 | 29.9700 | 29.0001 |
Travere Therapeutics, Inc. Earnings
Travere Therapeutics, Inc. Earnings Report: Per Share Travere Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Travere Therapeutics, Inc. Forecast Revenue Growth
Travere Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Travere Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $1.51 per share.
* Travere Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.